250 shipments are planed for now, from CREAPHARM CLINICAL SUPPLIES Le Haillan to the clinical sites in 7 European countries.
The clinical labeling in 11 languages and the strong support of the CREAPHARM’s depot partners contribute to meet the different local regulations.
“Our strategic alliance with DELPHARM & CREAPHARM has enabled us to take forward our compound to a Phase II clinical study as per the planned timelines. We look forward to continuing our successful collaboration for our next projects as well.”
Daniel GEHRLACH
ABOUT HMNC
HMNC Brain Health (HMNC Holding GmbH) is a global precision psychiatry biopharma company pioneering the development of personalized therapies powered by predictive companion diagnostics, leading to higher remission rates. The Company develops a unique pipeline for targeting both Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD). The Company has presence in both the Germany and the US and is backed by a renowned global VC, several family offices, and a strategic healthcare investor.
HMNC’s development pipeline includes 2 precision psychiatry programs in which it aspires to develop a V1bR antagonist with a companion diagnostic (V1bCDx), and a CRHR1 antagonist with its companion diagnostic (CRHR1CDx).
Additionally, in a joint venture with Develco Pharma, the company is developing an oral-prolonged release formulation, KET01, a racemic ketamine with minimal dissociative side effects. The pharmacokinetic profile of KET01 could significantly improve the risk profile and patient convenience in TRD population, by minimizing dissociative side effects compared to the currently applied intravenous and intranasal ketamine therapies.
ABOUT DELPHARM
DELPHARM DEVELOPMENT is the business unit of DELPHARM offering full development services for a large range of dosage forms for new chemical entities or innovative fixed dose combinations thereof clinical batches supply for Phase 1-3 for OSD and injectable dosage forms. DELPHARM is a worldwide leader in contract development and manufacturing (CDMO) of medicines for pharmaceutical companies.
ABOUT CREAPHARM
CREAPHARM CLINICAL SUPPLIES is the pharmaceutical industry global partner for Clinical Trial Supply Management (CTSM), specialized in clinical packaging, labeling and clinical logistics.
With the aim to provide high value-added services that meet the specific needs of each client, CREAPHARM offers a tailor-made approach. The teams give and bring their best to achieve operational excellence and maximize the success of each clinical trial.